Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 345.00p 330.00p 360.00p 348.00p 345.00p 348.00p 0 08:11:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 19.6 233

Eco Animal Health Share Discussion Threads

Showing 1001 to 1025 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
24/4/2019
03:19
Have been having a look at the financials here & was a little surprised to see the only broker forecast (Peel Hunt I believe) saying EPS of 23.8p for FY18. This seems a pretty significant jump on prior yr & current trend given HY performance, add prior seasonality & this would seem to be quite a stretch. Anyone got a POV on why such a significant increase ? Lot to like here so keen to understand whats going on.
tudes100
15/4/2019
12:58
Thanks for that interesting and encouraging read, astonedt. It’s worth quoting the final summing up : “ECO has a global presence with well-established routes to market, we have a strong and developing R&D pipeline which will enable us to expand both geographically and across indications. We are profitable, we are cash generative and I believe that the company has enormous potential.”
aimingupward2
15/4/2019
12:27
Q&A with Marc Loomes discussing their recent regulatory approvals, new developments in upcoming vaccinations and their plans for the near future - http://bit.ly/2v3fKbv
astonedt
08/4/2019
08:00
Http://investing.thisismoney.co.uk/broker-views/index/date/08-04-2019 Peel Hunt Buy 725.00 - Reiterates
ariane
04/4/2019
12:27
topvest, you have no idea what you are talking about, do you?
johnwig
03/4/2019
11:26
I have asked the company and got an immediate reply saying that some markets follow EU approvals whilst in other cases they will accept most of the dossier which shortcuts the process.
aimingupward2
03/4/2019
10:27
All a bit confusing, I agree. They say that “This marketing authorisation is very significant as it provides an opportunity to roll out the approval beyond the EU into the multi-million dollar large international poultry markets.” How or why is that? It suggest s that a number of markets just follow EU approvals, which is rather surprising.
aimingupward2
02/4/2019
20:11
Well its positive. No idea how positive though I'm afraid!
topvest
02/4/2019
19:23
Trying to work out the significance of today’s announcement. In 2016 they got EMA authorization for Aivlosin625 for chickens laying eggs for human consumption; I am going on the basis that today’s announcement widens it for quote breeding chickens producing eggs, for hatching broiler stock and for replacement layers unquote. I am further surmising that this is a smaller market than for chicken laying eggs and as the EU is just 8% of EAH sales, that explains why the markets yawned today. Am I right? I see the reference to replacement layers and I also note that in the interims when discussing the Vietnam Aivlosin 625 approval they referenced EU approval for commercial layers and thus I am abit confused.
cerrito
02/4/2019
10:31
Another regulatory approval. “ECO Animal Health Limited (ECO) has received a marketing authorisation from the European Medicines Agency (EMA) for the use of Aivlosin® 625 mg/g Water Soluble Granules (WSG) in breeding chickens.” “The EU has five per cent of the world’s layer and ten per cent of the world’s broiler parent stock. This marketing authorisation is very significant as it provides an opportunity to roll out the approval beyond the EU into the multi-million dollar large international poultry markets. This will enable ECO to capitalise on the considerable global potential for Aivlosin® which offers a safe and highly effective medication for Mycoplasma infections in high value breeding birds”.
aimingupward2
07/3/2019
08:09
Agreed. This is a bit of a shock announcement. Not flagged previously I believe. Peter Lawrence is 70, but he's being replaced by someone even older. Maybe its time to wind back his activities. Anyway best wishes to him.
topvest
07/3/2019
07:15
Hats off to PL, hope he has a well earned retirement. He has made this company what it is today and leave it in extremely good health.
audigger
05/3/2019
20:49
Well the regulatory approvals keep coming. Looking much more positive for 2019 I think. This is a quality company that is growing nicely. Unlike many fraudulent or window-dressed companies, its growth is not straight line and impacted by forex as well. The direction of travel is in the medium term very positive though.
topvest
05/3/2019
15:40
Another regulatory approval. “This approval allows ECO to start selling Aivlosin® in India for the medication of drinking water for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption” India is ranked second in the world in terms of egg laying poultry.
aimingupward2
13/2/2019
09:30
Two further licensing deals this month, with universities, to register and commercialise vaccines for poultry. One with Georgia uni’ and now with Ghent. Encouraging to see this additional field of activity developing.
aimingupward2
06/2/2019
21:18
Yes, nice to see this recovering lost ground at last. Its a class company.
topvest
06/2/2019
13:14
500p paid for a modest 1000 shares buy. Sp moving up steadily now which is nice to see for lt holders.
aimingupward2
31/1/2019
10:37
A couple of big trades have gone through at mid price. If they’re buys, that’s encouraging. If they’re sells it suggests that stock is wanted so it’s good either way and makes it likely that 500p will soon be reached and passed. Edit: - followed by a 10,760 shares buy.
aimingupward2
30/1/2019
09:20
Is it preparing to leap back though 500p; lets hope so!
audigger
14/1/2019
13:59
Some signs, at last, of an encouraging turnaround and that on a generally pretty poor day all round.
aimingupward2
27/12/2018
18:56
I was pleasantly surprised reading today#s RNS of the reduction by Merian in their holding and the share price had absorbed it but I guess the counterpart to this sale is the additions by Blackrock announced on Dec 13.
cerrito
15/12/2018
21:24
There is a seasonal weighting I believe.
topvest
15/12/2018
20:42
Just had the chance to run through the interims properly. I am new in this. I note that in this last half year fully diluted eps declined from 7.69p to 7.46 compared to the previous half year ending March 2018. I would not have thought that the rating of this share would tolerate a decline in eps but have been unable to work out if this is seasonal. Any historic perspective welcome. PS Such a joy to read financials without adjustments/extraordinary items PPS Saw the FX sensitivities on page 81 of the last AR and we will get a fillip with the current rate against the dollar which is the most important for EAH but much less for the second most important the Renmenibi where at today#s 8.69 £ has weakened much less.
cerrito
15/12/2018
16:15
I agree with you aimingupward2 and was surprised at this RNS that there has been a buyer with such a soggy share price Note however as at 25/9/18 they did have 2.21%; even so heaven only knows what the share price would have been if they had not added 2%.
cerrito
13/12/2018
15:10
Blackrock taking the opportunity to build up a 5% stake. Somebody, then, showing a bit of confidence
aimingupward2
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191014 04:24:16